Skip to main content

Advertisement

Log in

Interleukin-2 production by persons with the generalized lymphadenopathy syndrome or the acquired immune deficiency syndrome

  • Original Articles
  • Published:
Journal of Clinical Immunology Aims and scope Submit manuscript

Abstract

We measured production of interleukin-2 (IL-2) by phytohemagglutinin-stimulated peripheral blood mononuclear cells from 27 heterosexual persons, 43 asymptomatic homosexual men, 34 homosexual men with generalized lymphadenopathy syndrome (GLS), and 21 patients with acquired immune deficiency syndrome (AIDS). Asymptomatic heterosexual and homosexual subjects produced comparable amounts of IL-2, but 8 of 11 AIDS patients with opportunistic infections and two of three AIDS patients with both opportunistic infections and Kaposi's sarcoma failed to produce detectable amounts of IL-2; all seven AIDS patients with only Kaposi's sarcoma produced IL-2. The titer of IL-2 produced by the AIDS patients correlated with the percentage of helper T lymphocytes (Leu 3a+ cells) but not with the percentage of suppressor T lymphocytes (Leu 2a+ cells). This observation is interpreted as indicating that failure to produce IL-2 by AIDS patients is most likely due to depletion of IL-2-producing cells, although an abnormality of T-cell function has not been excluded. In addition, three of eight AIDS patients who did not produce IL-2 produced supernatants that inhibited growth of IL-2-dependent cells in the presence of IL-2. These observations suggest that measurement of endogenous IL-2 production may be important in selecting patients for therapy with IL-2.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Gottlieb MS, Groopman JE, Weinstein WM, Fahey JL, Detels R: The acquired immunodeficiency syndrome. Ann Intern Med 99:208–220, 1983

    Google Scholar 

  2. Fauci AS, Macher AM, Longo DL, Lane HC, Rook AH, Masur H, Gelmann EP: Acquired immunodeficiency syndrome: Epidemiologic clinical, immunologic, and therapeutic considerations. Ann Intern Med 100:92–106, 1984

    Google Scholar 

  3. Fahey JL, Prince H, Weaver M, Groopman J, Visscher B, Schwartz K, Detels R: Quantitative changes in T helper or T suppressor/cytotoxic lymphocyte subsets that distinguish acquired immune deficiency syndrome from other subset disorders. Am J Med 76:95–100, 1984

    Google Scholar 

  4. Gillis S: Interleukin 2: Biology and biochemistry. J Clin Immunol 3:1–13, 1983

    Google Scholar 

  5. Kawase I, Brooks CG, Kuribayashi K, Olabuenaga S, Newman W, Gillis S, Henney CS: Interleukin-2 induces γ-interferon production: Participation of macrophages and NK-like cells. J Immunol 131:288–292, 1983

    Google Scholar 

  6. Flomenberg N, Welte K, Mertelsman N, Kerman N, Ciobanu N, Venuta S, Feldman S, Kruger G, Kirkpatrick D, DuPont B, O'Reilly R: Immunologic effects of interleukin 2 in primary immunodeficiency disease. J Immunol 130:2644–2650, 1983

    Google Scholar 

  7. Ciobanu N, Welte K, Kruger G, Vanuta S, Gold J, Feldman SP, Wang CY, Koziner B, Moore MAS, Safai B, Mertelsmann R: Defective T-cell response to PHA and mitogenic monoclonal antibodies in male homosexuals with acquired immunodeficiency syndrome and its in vitro correction by interleukin 2. J Clin Immunol 3:332–340, 1983

    Google Scholar 

  8. Ebert EC, Cassens B, Stoll D, Lipschutz WH, Hauptman SP: Interleukin-2 corrects the immunoregulatory cell defect in acquired immunodeficiency syndrome. Clin Res 31:311A, 1983

    Google Scholar 

  9. Alcocer-Verela J, Alarcon-Segovia D: Decreased production of and response to interleukin-2 by cultured lymphocytes from patients with systemic lupus erythematosus. J Clin Invest 69:1388–1392, 1982

    Google Scholar 

  10. Linker-Israeli M, Bakke A, Kitridou R, Gendler S, Gillis S, Horwitz D: Defective production of interleukin 1 and interleukin 2 in patients with systemic lupus erythematosus. J Immunol 130:2651–2655, 1983

    Google Scholar 

  11. Gillis S, Kozak M, Durante M, Weksler ME: Immunologic studies of aging. Decreased production of and response to T cell growth factor by homphocytes from aged humans. J Clin Invest 67:937–942, 1981

    Google Scholar 

  12. Rey A, Klein B, Zagury D, Thierry C, Serrou B: Diminished interleukin-2 activity production in cancer patients bearing solid tumors and its relationship to natural killer cells. Immunol Lett 6:175–178, 1983

    Google Scholar 

  13. Rook AH, Masur H, Lane HC, Frederick W, Kasahara T, Macher AM, Djeu JY, Manischewitz J, Jackson L, Fauci AS, Quinnan GV: Interleukin-2 enhances the depressed natural killer and cytomegalovirus-specific cytotoxic activities of lymphocytes from patients with the acquired immune deficiency syndrome. J Clin Invest 72:398–403, 1983

    Google Scholar 

  14. Lifson JD, Benike CJ, Mark DF, Koth SK, Engleman EB: Human recombinant interleukin-2 partly reconstitutes deficiency in vitro immune responses of lymphocytes from patients with AIDS. Lancet 1:698–702, 1984

    Google Scholar 

  15. Centers for Disease Control: Persistent, generalized lymphadenopathy among homosexual males. MMWR 31:249–51, 1982

    Google Scholar 

  16. Jaffe HW, Bregman DJ, Selik RM: Acquired immune deficiency syndrome in the United States: The first 1000 cases. J Infect Dis 148:339–345, 1983

    Google Scholar 

  17. Kappler JW, Skidmore B, White J, Marrack P: Antigeninducible, H-2-restricted, interleukin-2-producing T-cell hybridomas. Lack of independent antigen and H-2 recognition. J Exp Med 153:1198–1214, 1981

    Google Scholar 

  18. Gillis S, Ferm MM, Ou W, Smith KA: T cell growth factor: Parameters of production and a quantitative microassay for activity. J Immunol 120:2027–2032, 1978

    Google Scholar 

  19. Watson J: Continuous proliferation of murine antigen-specific helper T-lymphocytes in culture. J Exp Med 150:1510–1519, 1979

    Google Scholar 

  20. Mishell R, Dutton R: Immunization of dissociated spleen cell cultures from normal mice. J Exp Med 126:423–442, 1967

    Google Scholar 

  21. Lugar TA, Smolen JS, Chused TM, Steinberg AD, Oppenheim JJ: Human lymphocytes with either the OKT4 or OKT8 phenotype produce interleukin 2 in culture. J Clin Invest 70:470–473, 1982

    Google Scholar 

  22. Meuer SC, Hussey RE, Penta AC, Fitzgerald KA, Stadler BM, Schlossman SF, Reinherz EL: Cellular origin of interleukin 2 (IL-2) in man: evidence for stimulus restricted IL 2 production by T4+ and T8+ T lymphocytes. J Immunol 129:1076–1079, 1982

    Google Scholar 

  23. Metroka CE, Cunningham-Rundles S, Pollack MS, Sonnabend JA, Davis JM, Gordon B, Fernandez RD, Mouradian J: Generalized lymphadenopathy in homosexual men. Ann Intern Med 99:585–591, 1983

    Google Scholar 

  24. Brun-Vezinet F, Rouzidux C, Barre-Sinoussi F, Klatzmann D, Saimot AG, Rosenbaum W, Christol D, Gluckmann JC, Montagnier L, Chermann JC: Detection of IgG antibodies to lymphadenopathy-associated virus in patients with AIDS or lymphadenopathy syndrome. Lancet 1:1253–1256, 1984

    Google Scholar 

  25. Safai B, Sarngadharan MG, Groopman JE, Arnett K, Popovic M, Sliski A, Schupbach J: Seroepidemiological studies of human T-lymphotropic retrovirus type III in acquired immunodeficiency syndrome. Lancet 1:1438–1440, 1984

    Google Scholar 

  26. Barre-Sinoussi F, Chermann JC, Rey F, Nugeyre MT, Chamaret S, Gruest J, Dauguet C, Axler-Blin C, Vezinet-Brun F, Rouzioux C, Rozenbaum W, Montagnier L: Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS). Science 220:868–871, 1983

    Google Scholar 

  27. Gallo RC, Salahuddin SZ, Popovic M, Shearer GM, Kaplan M, Haynes BF, Palker TJ, Redfield R, Oleske J, Safai B, White G, Foster P, Markham PD: Frequent detection and isolation of cytopathic retroviruses (HTLV-III) from patients with AIDS and at risk for AIDS. Science 224:500–503, 1984

    Google Scholar 

  28. Prince HE, Kermani-Arab V, Fahey JL: Depressed interieukin-2 receptor expression in acquired immune deficiency and lymphadenopathy syndromes. J Immunol 133:1313–1317, 1984

    Google Scholar 

  29. Murray HW, Rubin BY, Masur H, Roberts RB: Impaired production of lymphokines and immune (gamma) interferon in the acquired immunodeficiency syndrome. N Engl J Med 310:883–889, 1984

    Google Scholar 

  30. Kasahara T, Hooks JJ, Dougherty SF, Oppenheim JJ: Interleukin 2-mediated immune interferon (IFN-γ) production by human T cells and T cell subsets. J Immunol 130:1784–1789, 1983

    Google Scholar 

  31. Reddy MM, Pinyavat N, Grieco MH: Interleukin 2 augmentation of natural killer cell activity in homosexual men with acquired immune deficiency syndrome. Infect Immun 44:339–343, 1984

    Google Scholar 

  32. Lane HC, Masur H, Rook AH, Quinnan GV, Gelmann E, Steis R, Longo D, Palestin A, Macher A, Fauci AS: Treatment of patients with the acquired immunodeficiency syndrome with interleukin-2 or γ-interferon. Clin Res 32:351A, 1984

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kirkpatrick, C.H., Davis, K.C., Horsburgh, C.R. et al. Interleukin-2 production by persons with the generalized lymphadenopathy syndrome or the acquired immune deficiency syndrome. J Clin Immunol 5, 31–37 (1985). https://doi.org/10.1007/BF00915166

Download citation

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00915166

Key words

Navigation